Supplements
Ipamorelin (12MG) / CJC-129 No Dac (6MG)
Overview
Effectiveness scored 45 due to consistent preclinical/human PK evidence for GH/IGF elevation (e.g., CJC-1295 2-10x GH increase for days; PMID:16352683), but no proven clinical benefits for common claims like muscle gain/fat loss; sole efficacy trial failed (PMID:25331030). Safety at 30 reflects FDA concerns on immunogenicity/aggregation in compounded peptides, sparse long-term data, and GH class effects (neoplasms, diabetes risk), despite good short-term tolerability in small studies. Quality lo
Key strengths
- Synergistic GH pulse amplification without cortisol/ACTH rise
- Short-term tolerability in small human studies
- Anecdotal reports of improved recovery/sleep
Our analysis
Avoid this product due to lack of FDA approval, limited clinical evidence beyond GH stimulation, and notable safety risks including immunogenicity and unknown long-term effects. Opt for approved GH therapies if medically indicated under supervision.
Frequently asked questions
- Is Ipamorelin (12MG) / CJC-129 No Dac (6MG) worth buying?
- Ipamorelin (12MG) / CJC-129 No Dac (6MG) has a Verify Influencers trust score of 38/100 based on ingredient quality, clinical evidence, and third-party testing.
- What is the trust score for Ipamorelin (12MG) / CJC-129 No Dac (6MG)?
- Ipamorelin (12MG) / CJC-129 No Dac (6MG) scored 38 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.
Browse all scored products · How products are scored